How have BBLGW shares performed in 2024?

Bone Biologics' stock was trading at $3.92 at the start of the year. Since then, BBLGW shares have increased by 461.2% and is now trading at $22.00. View the best growth stocks for 2024 here .

Are investors shorting Bone Biologics?

Bone Biologics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 1,300 shares, an increase of 44.4% from the March 31st total of 900 shares. Based on an average trading volume of 1,800 shares, the days-to-cover ratio is currently 0.7 days. View Bone Biologics' Short Interest .

When did Bone Biologics' stock split?

Shares of Bone Biologics reverse split on Wednesday, June 7th 2023. The 1-30 reverse split was announced on Wednesday, June 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

How do I buy shares of Bone Biologics?

Shares of BBLGW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:BBLGW

Bone Biologics (BBLGW) Stock Price, News & Analysis

→ These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad)

Free BBLGW Stock Alerts

$22.00

-1.04 (-4.51%)

(As of 04/26/2024 ET)

Compare

Today's Range: $21.00
▼
$22.00
50-Day Range: $2.87
▼
$25.01
52-Week Range: $0.43
▼
$44.15

Volume: 1,654 shs
Average Volume: 2,960 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials SEC Filings Short Interest Social Media

Get Bone Biologics alerts:

Ad True Market Insiders

Exposed: 10 CENT Crypto to Explode April 20th?

The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…

Click For My #1 FREE Crypto for 2024

About Bone Biologics

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

BBLGW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BBLGW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive BBLGW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bone Biologics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Medical Devices
Sub-Industry: N/A
Current Symbol: NASDAQ:BBLGW
CUSIP: N/A
CIK: 1419554
Web: www.bonebiologics.com
Phone: 781-552-4452
Fax: N/A
Employees: 2
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. Jeffrey Frelick (Age 58)
CEO & President
Comp: $325k
Ms. Deina H. Walsh (Age 60)
Chief Financial Officer
Comp: $212.5k
Dr. Shun'ichi Kuroda
Co-Founder & Member of Scientific Advisory Board

Key Competitors

View All Competitors

BBLGW Stock Analysis - Frequently Asked Questions

How have BBLGW shares performed in 2024?: Bone Biologics' stock was trading at $3.92 at the start of the year. Since then, BBLGW shares have increased by 461.2% and is now trading at $22.00.
View the best growth stocks for 2024 here.
Are investors shorting Bone Biologics?: Bone Biologics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 1,300 shares, an increase of 44.4% from the March 31st total of 900 shares. Based on an average trading volume of 1,800 shares, the days-to-cover ratio is currently 0.7 days.
View Bone Biologics' Short Interest.
When did Bone Biologics' stock split?: Shares of Bone Biologics reverse split on Wednesday, June 7th 2023. The 1-30 reverse split was announced on Wednesday, June 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.
How do I buy shares of Bone Biologics?: Shares of BBLGW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BBLGW) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial